Top Headlines: Testing continues for Covid vaccine, Fitch withdraws BJCC rating

1st patient dosed with forerunner to a Covid vaccine UAB is testingAltimmune said the first patient was dosed in the company’s Phase Ib clinical trial of NasoShield, an Anthrax vaccine whose intranasal delivery platform is the basis of a Covid-19 vaccine the company is working on, with tests on mice now ongoing at the University of Alabama at Birmingham. —  Genetic Engineering…

Thank you for reading!

To continue reading this article you must be registered and logged into this site. If you already have an account please login now, otherwise you can click here to register for new account. Registration is FREE.

Login       Register

The latest Alabama business news delivered to your inbox